Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain

Infection and Immunity

Volumn 76, Issue 8, 2008, Pages 3808-3816

  Blisnick, Thierry ^a   Ave, Patrick ^a   Huerre, Michel ^a   Carniel, Elisabeth ^a   Demeure, Christian E ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; EV 76; IP 32621; IP 32680; IP 32721; IP 32860; IP 32896; IP 32908; IP 32953; IP 33098; LIVE VACCINE; SUPERANTIGEN; BACTERIAL DNA; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; VIRULENCE FACTOR; YERSINIA PSEUDOTUBERCULOSIS DERIVED MITOGEN; YERSINIA PSEUDOTUBERCULOSIS-DERIVED MITOGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM PILUS; BUBONIC PLAGUE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG SCREENING; EXPERIMENTAL MOUSE; FEMALE; GENETIC SIMILARITY; GENETIC STABILITY; HISTOPATHOLOGY; IMMUNIZATION; INOCULATION; INTESTINE; LIVER; LOADING DRUG DOSE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PATHOGENICITY ISLAND; PLAGUE; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVOCATION TEST; SPLEEN; STRAIN IDENTIFICATION; VACCINATION; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; ANIMAL; BLOOD; FIMBRIA; GENETICS; GENOMIC ISLAND; HUMAN; IMMUNOLOGY; LYMPH NODE; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOGENICITY; PATHOLOGY; SURVIVAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BLOOD; DNA, BACTERIAL; FEMALE; FIMBRIAE, BACTERIAL; GENOMIC ISLANDS; HUMANS; LIVER; LYMPH NODES; MICE; PLAGUE; POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL ANALYSIS; VACCINES, ATTENUATED; VIRULENCE FACTORS; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 48849088951     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00034-08     Document Type: Article

References (51)

1. Achtman, M., K. Zurth, C. Morelli, G. Torrea, A. Guiyoule, and E. Carniel. 1999. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. USA 96:14043-14048.
2. Alonso, J. M., A. Joseph-Francois, D. Mazigh, H. Bercovier, and H. H. Mollaret. 1978. Résistance à la peste de souris expérimentalement infectées par Yersinia enterocolitica. Ann. Microbiol. Inst. Pasteur 129b:203-207.
3. Anderson, G. W., D. G. Heath, C. R. Bolt, S. L. Welkos, and A. M. Friedlander. 1998. Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am. J. Trop. Med. Hyg. 58:793-799.
4. Andrews, G. P., D. G. Heath, G. W. Anderson, S. L. Welkos, and A. M. Friedlander. 1996. Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect. Immun. 64:2180-2187.
5. Anisimov, A. P., L. E. Lindler, and G. B. Pier. 2004. Intraspecific diversity of Yersinia pestis. Clin. Microbiol. Rev. 17:434-464.
6. Bubeck, S. S., and P. H. Dube. 2007. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine. Clin. Vaccine Immunol. 14:1235-1238.
7. Cangiani, E. E., F. R. Guiraldi, S. E. Pinto, and B. M. de Medeiros. 2007. Kinetics of B-cell response during Yersinia enterocolitica infection in resistant and susceptible strains of mice. Immunol. Investig. 36:387-402.
8. Chain, P. S., E. Carniel, F. W. Larimer, J. Lamerdin, P. O. Stoutland, W. M. Regala, A. M. Georgescu, L. M. Vergez, M. L. Land, V. L. Motin, R. R. Brubaker, J. Fowler, J. Hinnebusch, M. Marceau, C. Medigue, M. Simonet, V. Chenal-Francisque, B. Souza, D. Dacheux, J. M. Elliott, A. Derbise, L. J. Hauser, and E. Garcia. 2004. Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc. Natl. Acad. Sci. USA 101:13826-13831.
9. Collyn, F., A. Billault, C. Mullet, M. Simonet, and M. Marceau. 2004. YAPI, a new Yersinia pseudotuberculosis pathogenicity island. Infect. Immun. 72:4784-4790.
10. Collyn, F., M. A. Lety, S. Nair, V. Escuyer, A. Ben Younes, M. Simonet, and M. Marceau. 2002. Yersinia pseudotuberculosis harbors a type IV pilus gene cluster that contributes to pathogenicity. Infect. Immun. 70:6196-6205.
11. Corthesy, B., H. R. Gaskins, and A. Mercenier. 2007. Cross-talk between probiotic bacteria and the host immune system. J. Nutr. 137:781S-790S.
12. De Almeida, A. M., A. Guiyoule, I. Guilvout, I. Iteman, G. Baranton, and E. Carniel. 1993. Chromosomal irp2 gene in Yersinia: distribution, expression, deletion and impact on virulence. Microb. Pathog. 14:9-21.
13. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
14. Flashner, Y., E. Mamroud, A. Tidhar, R. Ber, M. Aftalion, D. Gur, S. Lazar, A. Zvi, T. Bino, N. Ariel, B. Velan, A. Shafferman, and S. Cohen. 2004. Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates. Infect. Immun. 72:908-915.
15. Fukushima, H., Y. Matsuda, R. Seki, M. Tsubokura, N. Takeda, F. N. Shubin, I. K. Paik, and X. B. Zheng. 2001. Geographical heterogeneity between Far Eastern and Western countries in prevalence of the virulence plasmid, the superantigen Yersinia pseudotuberculosis-derived mitogen, and the high-pathogenicity island among Yersinia pseudotuberculosis strains. J. Clin. Microbiol. 39:3541-3547.
16. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337:677-680.
17. Green, M., D. Rogers, P. Russell, A. J. Stagg, D. L. Bell, S. M. Eley, R. W. Titball, and E. D. Williamson. 1999. The SCID/Beige mouse as a model to investigate protection against Yersinia pestis. FEMS Immunol. Med. Microbiol. 23:107-113.
18. Heath, D. G., G. W. Anderson, J. M. Mauro, S. L. Welkos, G. P. Andrews, J. Adamovicz, and A. M. Friedlander. 1998. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine. Vaccine 16:1131-1137.
19. Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11:S45-S53.
20. Inglesby, T. V., D. T. Dennis, D. A. Henderson, J. G. Bartlett, M. S. Ascher, E. Eitzen, A. D. Fine, A. M. Friedlander, J. Hauer, J. F. Koerner, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. M. Perl, P. K. Russell, M. Schoch-Spana, and K. Tonat. 2000. Plague as a biological weapon: medical and public health management. JAMA 283:2281-2290.
21. Iwasaki, A., and B. L. Kelsall. 2001. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J. Immunol. 166: 4884-4890.
22. Kotton, C. N., and E. L. Hohmann. 2004. Enteric pathogens as vaccine vectors for foreign antigen delivery. Infect. Immun. 72:5535-5547.
23. Leary, S. E. C., E. D. Williamson, K. F. Griffin, P. Russell, S. M. Eley, and R. W. Titball. 1995. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:2854-2858.
24. Lesic, B., and E. Carniel. 2005. Horizontal transfer of the high-pathogenicity island of Yersinia pseudotuberculosis. J. Bacteriol. 187:3352-3358.
25. Logsdon, L. K., and J. Mecsas. 2003. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect. Immun. 71:4595-4607.
26. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301-305.
27. Meyer, K. F., D. C. Cavanaugh, P. J. Bartelloni, and J. D. Marshall, Jr. 1974. Plague immunization. I. Past and present trends. J. Infect. Dis. 129(Suppl):S13-S18.
28. Montminy, S. W., N. Khan, S. McGrath, M. J. Walkowicz, F. Sharp, J. E. Conlon, K. Fukase, S. Kusumoto, C. Sweet, K. Miyake, S. Akira, R. J. Cotter, J. D. Goguen, and E. Lien. 2006. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 7:1066-1073.
29. Oyston, P. C. F., E. D. Williamson, S. E. C. Leary, S. M. Eley, K. F. Griffin, and R. W. Titball. 1995. Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague. Infect. Immun. 63:563-568.
30. Parkhill, J., B. W. Wren, N. R. Thomson, R. W. Titball, M. T. G. Holden, M. B. Prentice, M. Sebaihia, K. D. James, C. Churcher, K. L. Mungall, S. Baker, D. Basham, S. D. Bentley, K. Brooks, A. M. Cerdeno-Tarraga, T. Chillingworth, A. Cronin, R. M. Davies, P. Davis, G. Dougan, T. Feltwell, N. Hamlin, S. Holroyd, K. Jagels, A. V. Karlyshev, et al. 2001. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413:523-527.
31. Philipovskiy, A. V., and S. T. Smiley. 2007. Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection. Infect. Immun. b:878-885.
32. Pilette, C., Y. Ouadrhiri, V. Godding, J. P. Vaerman, and Y. Sibille. 2001. Lung mucosal immunity: immunoglobulin-A revisited. Eur. Respir. J. 18:571-588.
33. Pouillot, F., A. Derbise, M. Kukkonen, J. Foulon, T. K. Korhonen, and E. Carniel. 2005. Evaluation of O-antigen inactivation on Pla activity and virulence of Yersinia pseudotuberculosis harbouring the pPla plasmid. Microbiology 151:3759-3768.
34. Ratsitorahina, M., S. Chanteau, L. Rahalison, L. Ratsifasoamanana, and P. Boisier. 2000. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 355:111-113.
35. Roggenkamp, A., A. M. Geiger, L. Leitritz, A. Kessler, and J. Heesemann. 1997. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect. Immun. 65:446-451.
36. Simonet, M., P. Berche, D. Mazigh, and M. Veron. 1985. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens. J. Med. Microbiol. 20:225-231.
37. Simpson, W. J., R. E. Thomas, and T. G. Schwan. 1990. Recombinant capsular antigen (Fraction-1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43:389-396.
38. Smiley, S. T. 2008. Current challenges in the development of vaccines for pneumonic plague. Expert Rev. Vaccines 7:209-221.
39. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
40. Taylor, V. L., R. W. Titball, and P. C. Oyston. 2005. Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague. Microbiology 151:1919-1926.
41. Une, T., and R. R. Brubaker. 1984. Roles of V antigen in promoting virulence and immunity in yersiniae. J. Immunol. 133:2226-2230.
42. Wake, A., H. Morita, and M. Wake. 1978. Mechanisms of long and short term immunity to plague. Immunology 34:1045-1052.
43. Welch, T. J., W. F. Fricke, P. F. McDermott, D. G. White, M. L. Rosso, D. A. Rasko, M. K. Mammel, M. Eppinger, M. J. Rosovitz, D. Wagner, L. Rahalison, J. E. Leclerc, J. M. Hinshaw, L. E. Lindler, T. A. Cebula, E. Carniel, and J. Ravel. 2007. Multiple antimicrobial resistance in plague: an emerging public health risk. PLoS ONE 2:e309.
44. Welkos, S. L., K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Freidlander. 1995. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis. Contrib. Microbiol. Immunol. 13:299-305.
45. WHO. 2004. Human plague in 2002 and 2003. Wkly. Epidemiol. Rec. 79:301-306.
46. WHO. 2003. WHO-UNICEF-UNFPA joint statement on the use of autodisable syringes in immunization services. World Health Organization, Geneva, Switzerland.
47. Williamson, E. D., S. M. Eley, K. F. Griffin, M. Green, P. Russell, S. E. C. Leary, P. C. F. Oyston, T. Easterbrook, K. M. Reddin, A. Robinson, and R. W. Titball. 1995. A new improved subunit vaccine for plague: the basis of protection. FEMS Immunol. Med. Microbiol. 12:223-230.
48. Williamson, E. D., H. C. Flick-Smith, C. LeButt, C. A. Rowland, S. M. Jones, E. L. Waters, R. J. Gwyther, J. Miller, P. J. Packer, and M. Irving. 2005. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73:3598-3608.
49. Winter, C. C., W. B. Cherry, and M. D. Moody. 1960. An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. Bull. Org. Mond. Santé/Bull. W. H. O. 23:408-409.
50. Zhang, Y., and J. B. Bliska. 2005. Role of macrophage apoptosis in the pathogenesis of Yersinia. Curr. Top. Microbiol. Immunol. 289:151-173.
51. Zhou, D., Y. Han, E. Dai, Y. Song, D. Pei, J. Zhai, Z. Du, J. Wang, Z. Guo, and R. Yang. 2004. Defining the genome content of live plague vaccines by use of whole-genome DNA microarray. Vaccine 22:3367-3374.